2005 (2) TMI 129 - SC - Central Excise

Product 'LICEL' classified as 'Medicament' under Chapter 30, not insecticide. Court emphasizes accurate tariff classification.

The Court upheld the Tribunal's decision to classify the product 'LICEL' under tariff sub-heading 3003.10 instead of 3808.10. Despite being perceived as ... Classification of goods under Customs Tariff - medicament exclusion from Chapter 38 - definition of 'Medicament' as comprising constituents mixed for therapeutic or prophylactic use - therapeutic and prophylactic use as determinative of tariff classification - tariff sub-heading 3003.10 (medicaments) - tariff sub-heading 3808.10 (insecticides)Medicament exclusion from Chapter 38 - definition of 'Medicament' as comprising constituents mixed for therapeutic or prophylactic use - therapeutic and prophylactic use as determinative of tariff classification - classification of goods under Customs Tariff - tariff sub-heading 3003.10 (medicaments) - tariff sub-heading 3808.10 (insecticides) - Whether the product 'LICEL', used to kill lice in human hair, is classifiable as a medicament under tariff sub-heading 3003.10 and excluded from Chapter 38 (tariff sub-heading 3808.10). - HELD THAT: - Chapter Note 1(c) to Chapter 38 excludes from Chapter 38 'medicaments under Heading No. 3003 or 3004.' Chapter Note 2(i) to Chapter 30 defines 'Medicament' to include products comprising two or more constituents mixed or compounded for therapeutic or prophylactic use. The Court accepted that LICEL's sole use is to kill lice in human hair and held that killing lice constitutes therapeutic use (curative/palliative) and prophylactic use (prevention of disease resulting from infestation). Consequently, LICEL falls within the meaning of 'Medicament' for the purposes of Chapter 30 and is therefore excluded from classification under Chapter 38. The Tribunal's reliance on its earlier decision in Pharmasia (concerning an identical product) and the Court's own view in ICPA Health Products (P) Ltd. supported classification under Tariff Heading 30.03. The Court found no error in the Tribunal's conclusion that the product is classifiable under tariff sub-heading 3003.10 and affirmed that conclusion. [Paras 5, 6, 7, 8]The product LICEL is a medicament within the meaning of Chapter 30 and is classifiable under tariff sub-heading 3003.10; the Tribunal's judgment is upheld and the appeal is dismissed.Final Conclusion: The Supreme Court affirmed the Tribunal's classification of LICEL as a medicament falling under tariff sub-heading 3003.10 (and excluded from Chapter 38) and dismissed the civil appeal. Issues: Classification of a product under tariff sub-heading 3808.10 or 3003.10.In this judgment, the issue revolves around the classification of a product known as 'LICEL' by the Appellants. The Appellants claim that their product should be classified under tariff sub-heading 3808.10, while the Department argues that it should be classified under tariff sub-heading 3003.10. The Tribunal, relying on a previous judgment concerning a similar product, held that the product falls under tariff sub-heading 3003.10. The Appellants contest this classification based on chemical examiners' reports and market perception of the product as an insecticide. However, the Court analyzes the definition of 'Medicament' under Chapter 30, emphasizing that even if a product is perceived as an insecticide, if it has therapeutic or prophylactic use, it cannot be classified under Chapter 38. The Court concludes that LICEL, used for killing lice in human hair, serves therapeutic and prophylactic purposes, making it a Medicament under Chapter 30 and excluding it from Chapter 38. This interpretation is consistent with a previous case involving a similar product. Consequently, the Court upholds the Tribunal's judgment, dismissing the Civil Appeal.This judgment highlights the importance of understanding the specific definitions and criteria outlined in the tariff headings and chapter notes for the proper classification of products. It underscores the significance of the therapeutic and prophylactic use of a product in determining its classification, even if it is commonly perceived as something else, such as an insecticide. The Court's analysis focuses on the legislative intent behind the classification system and the need for a comprehensive assessment of a product's intended use to ensure accurate classification under the relevant tariff sub-headings. The reference to previous judgments and consistency in interpretation further solidify the Court's decision in this case.